Atea Pharmaceuticals, Inc. · NASDAQ:AVIR
Atea Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 120 institutions reported holding Atea Pharmaceuticals, Inc., 74.1% of its shares. Largest: Fidelity, BlackRock and BML Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Atea Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 12M | 15.0% | +53,292 | Aug 13, 2026 |
| BlackRock | 8.72M | 10.9% | +285K | Aug 7, 2026 |
| BML Capital Management, LLC | 6.95M | 8.7% | −106K | Aug 7, 2026 |
| Tang Capital Management LLC | 4.81M | 6.0% | no change | Aug 14, 2026 |
| Vanguard | 4.09M | 5.1% | −224K | Aug 13, 2026 |
| Bain Capital Life Sciences Investors, LLC | 2.08M | 2.6% | −285K | Aug 14, 2026 |
| Acadian Asset Management LLC | 2.04M | 2.5% | +452K | Aug 13, 2026 |
| Geode Capital | 1.96M | 2.4% | +211K | Aug 12, 2026 |
| State Street | 1.65M | 2.1% | −42,236 | Aug 7, 2026 |
| Two Sigma | 1.51M | 1.9% | −357K | Aug 14, 2026 |